Welcome to Francis Academic Press

Academic Journal of Medicine & Health Sciences, 2024, 5(11); doi: 10.25236/AJMHS.2024.051102.

Clinical study of acupuncture combined with solinaxin in the intervention of bladder spasm after TURP in the elderly

Author(s)

Deng Xiongfeng1, Zhang Yujun2

Corresponding Author:
Zhang Yujun
Affiliation(s)

1Shaanxi University of Chinese Medicine, Xianyang, 712000, Shaanxi, China 

2Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, 712000, Shaanxi, China

Abstract

In this study, 60 cases were selected from the Department of Urology of the Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine from January 2019 to June 2021 for TURP treatment of prostatic hyperplasia, and were randomly divided into the control group and the experimental group, 30 cases in each group; the control group took oral Solinasin succinate tablets 5mg/times for 1 time/d on the same day of the postoperative period, and the drugs were stopped after the catheter was removed for 3d; the experimental group used millipercentre needles to stab jointly on the basis of the control group. The experimental group used millipercentre needling based on the control group to stab the acupoints such as Secondos, Zhongyi, Guanyuan, Sanyinjiao, etc., and the needles were left in place for 30 min after getting qi for 5 min. The results showed that the experimental group was lower than the control group in terms of the number of bladder spasms, duration, bladder flushing time, and bladder flushing fluid turn clear time in the 24h, 24-48h, and 48-72 h postoperative period (p<0.05). It was finally concluded that acupuncture combined with solinacin could more effectively relieve the symptoms of bladder spasm after TURP.

Keywords

Solinazine succinate; Transurethral resection of prostate; Bladder spasm; acupuncture

Cite This Paper

Deng Xiongfeng, Zhang Yujun. Clinical study of acupuncture combined with solinaxin in the intervention of bladder spasm after TURP in the elderly. Academic Journal of Medicine & Health Sciences (2024), Vol. 5, Issue 11: 8-13. https://doi.org/10.25236/AJMHS.2024.051102.

References

[1] Langan RC.Benign Prostatic Hyperplasia[J].Prim Care, 2019, 46(2):223-232.PMID: 31030823.

[2] Te AE.Recent advances in prostatectomy for benign prostatic hyperplasia [J].F1000Res, 2019, 8: F1000 Faculty Rev-1528.PMID: 31508198.

[3] Lokeshwar SD, Harper BT, Webb E, et al. Epidemiology and treatment modalities for the management of benign prostatic hyperplasia [J].Transl Androl Urol, 2019, 8(5):529-539.PMID: 31807429.

[4] Levy A, Samraj GP.Benign prostatic hyperplasia: when to 'watch and wait', when and how to treat [J].Cleve Clin J Med, 2007. 74(3):S15-20.PMID: 17546829.

[5] Foster HE, Dahm P, Kohler TS, et al. Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 2019[J].Urol, 2019, 202(3):592-598.PMID: 31059668.

[6] Na Yanqun, Ye Zhangqun, Sun Yinghao, et al. Chinese guidelines for diagnosis and treatment of urologic diseases (2014 edition) [M]. Beijing: People's Health Press, 2014: 330-339.

[7] Agarwal V, Yadav SS, Kumar S, et al. Evaluating the role of extracellular vesicles as a biomarker under transmission electron microscope in prostate cancer and benign prostate hyperplasia patients[J]. Urologia, 2021:3915603211018677.PMID: 34024220.

[8] ZHANG Kaiyu, LIU Xiaohua. Research progress on risk factors for the development of benign prostatic hyperplasia[J]. World Digest of Latest Medical Information, 2019, 19(61):100-101.

[9] Cicero AFG, Allkanjari O, Busetto GM, et al. Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer [J].Arch Ital Urol Androl, 2019, 91(3).PMID: 31577095.

[10] Knight GM, Talwar A, Salem R, et al. Systematic Review and Meta-analysis Comparing Prostatic Artery Embolization to Gold-Standard Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia[J].Cardiovasc Intervent Radiol, 2021, 44(2):183-193.PMID: 33078236.

[11] Gai Qiongyan, Li Ping, Fu Qiaomei, et al. Summary of evidence on the care of bladder spasms after benign prostatic hyperplasia[J]. Journal of Nursing, 2021, 36(03):46-49.

[12] Peng XF, Lv XG, Xie H, et al. Effectiveness of Solifenacin for Managing of Bladder Spasms in Patients With Urethroplasty [J].Am J Mens Health, 2017, 11 (5): 1580-1587.PMID: 28669278.

[13] Lai YL, Wang SR. Clinical efficacy of solinacin in the prevention of bladder spasm after transurethral plasma prostatectomy versus electrodesiccation[J]. Chinese Journal of Gerontology, 2019, 39(18):4495-4498.

[14] Guan YP, He LL, Bai ZM. Current status and progress in the prevention and treatment of postoperative bladder spasm after transurethral electrolysis of the prostate[J]. Journal of practical clinical medicine, 2017, 21(15):230-234.

[15] Bayne AP, Herbst KW, Corbett ST, et al. Parental perception of bladder spasms and hematuria after surgery for vesicoureteral reflux: a prospective multicenter study[J].Pediatr Urol, 2020, 16(4):449-455.PMID: 32423705.

[16] YANG Longfei, JIANG Li. Current status and progress in the treatment of overactive bladder[J]. Journal of Difficult Diseases, 2019, 18(12):1279-1283.

[17] Soliman MG, El-Abd S, El-Gamal OM, et al. Mirabegron versus Solifenacin in Children with Overactive Bladder: Prospective Randomized Single-Blind Controlled Trial[J].Urol Int, 2021, 105(11-12):1011-1017.PMID: 34010843.

[18] Gratzke C, Chapple C, Mueller ER, et al. Efficacy and Safety of Combination Pharmacotherapy for Patients with Overactive Bladder: A Rapid Evidence Assessment[J].Eur Urol, 2019, 76(6):767-779.PMID: 31416636.

[19] Martin Way DA, Barrabino Martin R, Puche Sanz I, et al. The Effect of Anticholinergics for Prevention of Storage Symptoms After Prostate Photovaporization[J].Urol, 2019, 16(6):598-602. PMID: 30345494.

[20] Zhang Y, Wang S, Zu S, et al. Transcutaneous electrical nerve stimulation and solifenacin succinate versus solifenacin succinate alone for the treatment of overactive bladder syndrome: a double-blind randomized controlled study[J].PLoS One, 2021, 16(6)e0253040.PMID: 34161360.

[21] Duong V, Iwamoto A, Pennycuff J, et al. A systematic review of neurocognitive dysfunction with overactive bladder medications [J].Int Urogynecol. 2021, 32(10):2693-2702.PMID: 34213600.

[22] Park JY, Cho SJ, Lee SH, et al. Peripheral ERK modulates acupuncture-induced brain neural activity and its functional connectivity [J].Sci Rep. 2021, 11(1):5128.PMID: 33664320.

[23] Jiang Ziyan, Wang Ying. Exploration of the origin of the theory of "kidney masters water" and its analysis today[J]. Zhejiang Journal of Traditional Chinese Medicine, 2017, 09: 630-631.

[24] Qian Wei, Tao Wei, Xue Boxin, et al. Effect of traditional Chinese medicine rehabilitation therapy combined with western medicine in preventing postoperative bladder spasm in elderly patients with prostatic hyperplasia[J]. Chinese Journal of Gerontology, 2019, 39(20):5047-5049.

[25] Yang M, Xu Chengcheng, Huang Zhilan, et al. A case of neurogenic bladder-urinary retention treated from the theory of the dui pulse (in English)[J].World Journal of Acupuncture-Moxibustion, 2018, 28(01):63-65.

[26] Wu L, Zhang GC, Zhou XH, et al. Mechanism study of acupuncture to inhibit overactive bladder syndrome by regulating Hcn1 channel protein and Ca2+ concentration in bladder epithelial cells[J]. Shizhen Guomao Guomao, 2021, 32(04):995-998.

[27] Hao ZJ, Wang BP, Gao Y. Clinical observation of warm acupuncture assisted treatment of bladder spasm after electrocision for prostatic hyperplasia[J]. Modern Chinese Medicine Clinic, 2020, 27(06):17-20.